These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24168166)

  • 1. Clinical development of candidate HIV vaccines: different problems for different vaccines.
    Shapiro SZ
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):325-9. PubMed ID: 24168166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV vaccine development: strategies for preclinical and clinical investigation.
    Shapiro SZ
    AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1401-6. PubMed ID: 23379343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses.
    Ringel O; Vieillard V; Debré P; Eichler J; Büning H; Dietrich U
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29662026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the development of HIV-1 Tat-based vaccines.
    Caputo A; Gavioli R; Ensoli B
    Curr HIV Res; 2004 Oct; 2(4):357-76. PubMed ID: 15544457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current progress in the development of a prophylactic vaccine for HIV-1.
    Gamble LJ; Matthews QL
    Drug Des Devel Ther; 2010 Dec; 5():9-26. PubMed ID: 21267356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New directions for HIV vaccine development from animal models.
    McChesney MB; Miller CJ
    Curr Opin HIV AIDS; 2013 Sep; 8(5):376-81. PubMed ID: 23836045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadly neutralizing antibodies and vaccine design against HIV-1 infection.
    Wang Q; Zhang L
    Front Med; 2020 Feb; 14(1):30-42. PubMed ID: 31858368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing T Follicular Helper Cell Responses for HIV Vaccine Development.
    Niessl J; Kaufmann DE
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29921828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials.
    Gilbert PB; DeGruttola VG; Hudgens MG; Self SG; Hammer SM; Corey L
    J Infect Dis; 2003 Jul; 188(2):179-93. PubMed ID: 12854072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on clinical development of candidate HIV vaccines: different problems for different vaccines.
    McMichael A; Dorrell L
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):331-2. PubMed ID: 24606555
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary on Shapiro: clinical development of candidate HIV vaccines: different problems for different vaccines.
    Hope TJ; Betts MR
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):330. PubMed ID: 24620907
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges in mucosal HIV vaccine development: lessons from non-human primate models.
    Tuero I; Robert-Guroff M
    Viruses; 2014 Aug; 6(8):3129-58. PubMed ID: 25196380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in HIV vaccines inducing mucosal immune responses.
    Pavot V; Rochereau N; Lawrence P; Girard MP; Genin C; Verrier B; Paul S
    AIDS; 2014 Jul; 28(12):1701-18. PubMed ID: 25009956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of vaccine research and development: the human immunodeficiency virus (HIV).
    Girard MP; Osmanov SK; Kieny MP
    Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No acquisition: a new ambition for HIV vaccine development?
    Lakhashe SK; Silvestri G; Ruprecht RM
    Curr Opin Virol; 2011 Oct; 1(4):246-53. PubMed ID: 22081778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Designing an effective AIDS vaccine: strategies and current status].
    Coutsinos Z; Absi Z; Henin Y; Guillet JG; Launay O
    Rev Med Interne; 2008 Aug; 29(8):632-41. PubMed ID: 18258341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV vaccine efficacy trials: towards the future of HIV prevention.
    Kim D; Elizaga M; Duerr A
    Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV vaccine: Can it be developed in the 21st century?
    Verma R; Khanna P; Chawla S; Dhankar M
    Hum Vaccin Immunother; 2016; 12(1):222-4. PubMed ID: 26212081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials of HIV vaccines.
    Graham BS
    Annu Rev Med; 2002; 53():207-21. PubMed ID: 11818471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 vaccines: challenges and new perspectives.
    Excler JL; Robb ML; Kim JH
    Hum Vaccin Immunother; 2014; 10(6):1734-46. PubMed ID: 24637946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.